SWK Holdings Corporation is a specialized finance company focused on the global healthcare sector. It operates in two segments: Finance Receivables and Pharmaceutical Development. The Finance Receivables segment offers customized financing solutions to life science companies, institutions, and inventors. The Pharmaceutical Development segment comprises Enteris BioPharma, a clinical stage biopharmaceutical company offering formulation solutions built around its proprietary oral drug delivery technologies, the Peptelligence platform.